Tag

#AI drug discovery

6 articles

Insilico Medicine advances AI drug for IPF to Phase III trials

This article explains how AI-driven drug discovery works and why Insilico Medicine's advancement of an AI-discovered IPF treatment to Phase III trials represents a significant milestone in computational medicine.

Jul 712

science

Building a Scaffold-Split Random Forest QSAR Co-Scientist for EGFR Inhibitor Discovery Using ChEMBL, RDKit, SHAP, and BRICS

This article explains how a scaffold-split Random Forest QSAR model, combined with tools like ChEMBL, RDKit, SHAP, and BRICS, can autonomously identify and design novel EGFR inhibitors, demonstrating advanced AI applications in drug discovery.

Jul 67

Takeda signs US$600M AI drug discovery deal with Insilico

Takeda has entered a $600 million AI drug discovery collaboration with Insilico Medicine, leveraging AI to accelerate early-stage drug development across multiple therapeutic areas.

Jul 321

SandboxAQ brings its drug discovery models to Claude — no PhD in computing required

This article explains how AI-powered drug discovery models work and why integrating them into accessible platforms like Claude represents a major breakthrough in pharmaceutical research accessibility.

May 1859

The company that built TikTok’s algorithm is now designing drugs for diseases pharma called undruggable

ByteDance's Anew Labs, known for building TikTok's recommendation algorithm, is now using AI to design drugs for previously 'undruggable' diseases.

May 267

Eli Lilly signs $2.75 billion deal with AI drug developer Insilico Medicine

Learn how to use AI-powered tools for drug discovery by analyzing molecular structures and predicting drug properties using Python and machine learning.

Mar 2994